ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,929Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 2061

$1.8M Total Retail Price of All Prescriptions

Rank: 20 out of 2061

854 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 854 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 854 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 32,364 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
FUROSEMIDE 1,761 1,757 1 6
LEVOTHYROXINE SODIUM 1,528 1,495 2 3
OMEPRAZOLE 1,014 1,011 3 5
LISINOPRIL 914 884 4 2
SIMVASTATIN 877 869 5 1
NAMENDA 846 846 6 37
WARFARIN SODIUM 842 842 7 11
DONEPEZIL HCL 747 734 8 24
AMLODIPINE BESYLATE 706 690 9 4
MIRTAZAPINE 651 642 10 46
METOPROLOL TARTRATE 645 635 11 7
ESCITALOPRAM OXALATE 543 542 12 77
POTASSIUM CHLORIDE 534 525 13 16
TRAMADOL HCL 505 490 14 18
EXELON 496 496 15 94
BUSPIRONE HCL 428 423 16 115
GABAPENTIN 422 420 17 15
CITALOPRAM HBR 413 407 18 20
LANTUS 357 347 19 48
HYDROCODONE-ACETAMINOPHEN 341 340 S3 20 10
PREDNISONE 340 331 21 32
ALBUTEROL SULFATE 327 327 22 104
DIVALPROEX SODIUM 299 299 23 74
ATORVASTATIN CALCIUM 295 291 24 8
HYDROCHLOROTHIAZIDE 288 262 25 12
AZITHROMYCIN 280 266 26 34
ALENDRONATE SODIUM 275 275 27 25
DIGOXIN 261 261 28 56
METOPROLOL SUCCINATE 259 258 29 19
TRAZODONE HCL 245 232 30 39
GLIMEPIRIDE 237 228 31 33
LIDODERM 235 235 32 106
CLOPIDOGREL 233 231 33 29
SULFAMETHOXAZOLE-TRIMETHOPRIM 233 231 33 87
METFORMIN HCL 232 223 35 9
LACTULOSE 229 229 36 131
CIPROFLOXACIN HCL 227 225 37 54
PANTOPRAZOLE SODIUM 223 222 38 45
NYSTATIN 220 220 39 148
NITROGLYCERIN PATCH 217 217 40 205
DOXYCYCLINE HYCLATE 213 208 41 98
TAMSULOSIN HCL 209 202 42 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 204 194 43 27
CARVEDILOL 200 200 44 22
KLOR-CON M20 197 197 45 47
ALLOPURINOL 196 196 46 28
SERTRALINE HCL 195 190 47 21
QUETIAPINE FUMARATE 181 178 48 72
NOVOLOG 181 180 48 102
ATENOLOL 168 163 50 13
ROPINIROLE HCL 167 162 51 92
FINASTERIDE 166 166 52 86
FENTANYL 163 158 S2 53 84
LOSARTAN POTASSIUM 157 152 54 17
FLUTICASONE PROPIONATE 156 152 55 43
SPIRIVA 155 155 56 63
LEVOFLOXACIN 152 152 57 111
CYMBALTA 151 151 58 59
PRAVASTATIN SODIUM 150 148 59 14
CARBIDOPA-LEVODOPA 147 147 60 97
ISOSORBIDE MONONITRATE ER 145 145 61 42
PLAVIX 145 143 61 49
FAMOTIDINE 143 137 63 67
LEVETIRACETAM 142 142 64 102
POLYETHYLENE GLYCOL 3350 140 139 65 64
SPIRONOLACTONE 135 135 66 62
LEXAPRO 132 132 67 211
CEPHALEXIN 128 126 68 112
ADVAIR DISKUS 128 128 68 57
PROMETHAZINE HCL 116 116 R 70 119
DILTIAZEM 24HR CD 114 114 71 118
CEFTRIAXONE 111 110 72 228
TRAVATAN Z 109 109 73 245
NITROFURANTOIN MONO-MACRO 108 108 74 162
KLOR-CON M10 105 105 75 125
LIDOCAINE HCL 104 103 76 290
LOPERAMIDE 101 101 77 283
LATANOPROST 100 100 78 236
DIOVAN 91 91 79 41
DOXAZOSIN MESYLATE 87 87 80 81
ZOLPIDEM TARTRATE 87 85 80 23
BYSTOLIC 85 85 82 130
DILTIAZEM 24HR ER 84 84 83 108
MELOXICAM 84 77 83 44
PAROXETINE HCL 83 83 85 61
ACTONEL 83 83 85 231
CLONIDINE HCL 82 80 87 52
LOVASTATIN 80 80 88 35
FLUOCINONIDE 78 76 89 267
GENERLAC 76 76 90 233
TRICOR 76 67 90 128
AMOXICILLIN 76 75 90 121
LYRICA 75 68 93 83
VENLAFAXINE HCL ER 74 74 94 109
CEFUROXIME 72 72 95 170
IPRATROPIUM-ALBUTEROL 72 72 95 117
NEXIUM 71 67 97 26
GLIPIZIDE 66 63 98 55
CELEBREX 65 64 99 91
ENULOSE 65 65 99 262
TRIMETHOPRIM 65 65 99 331
VESICARE 63 63 102 269
CRESTOR 63 58 102 31
ONDANSETRON HCL 63 63 102 261
CLONIDINE 62 62 105 276
METRONIDAZOLE 61 61 106 223
TIMOLOL MALEATE 61 61 106 393
LIPITOR 60 60 108 70
NITROFURANTOIN 59 59 109 206
LORAZEPAM 58 58 110 96
RANITIDINE HCL 57 49 111 53
FLUCONAZOLE 57 57 111 200
DILTIAZEM ER 56 56 113 248
AMOX TR-POTASSIUM CLAVULANATE 54 54 114 113
LANTUS SOLOSTAR 53 43 115 76
HYDRALAZINE HCL 53 53 115 69
VERAPAMIL ER 52 52 117 100
SINGULAIR 51 51 118 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.